Qianglin injection is the alias of compound monoammonium glycyrrhizinate injection, which has the effects of anti-inflammatory and anti-allergic, and has therapeutic effect on liver function abnormality caused by hepatitis.
Compound monoammonium glycyrrhizinate injection has the effects of anti-inflammation, anti-allergy, protecting membrane structure and protecting the liver, and is suitable for the treatment of liver function abnormality caused by acute, chronic, and prolonged hepatitis; it can also be used as an adjuvant for the treatment of toxic hepatitis, traumatic hepatitis, and cancer; or used in the treatment of food or drug poisoning and drug allergy.
The drug should be contraindicated in patients who are allergic to the product, with severe hypokalemia, hypernatremia, hypertension, heart failure, renal failure. Adverse reactions such as nausea, vomiting, poor appetite (poor appetite), abdominal distension, dry mouth, swelling, headache, dizziness, itching of the skin, urticaria, palpitations, increased hypertension, etc., may occur after the use of the drug.
Specific medication should be administered under the guidance of a specialist, and should not be used without authorization.